Different formulations of vancomycin: In vitro antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus aureus

2018 ◽  
Vol 92 (4) ◽  
pp. 332-337
Author(s):  
Franciele Viana Fabri ◽  
Mayara Assumpção Lolis ◽  
Marina Gimenes ◽  
Maria Cristina Bronharo Tognim ◽  
Silvana Martins Caparroz-Assef
2011 ◽  
Vol 64 (8) ◽  
pp. 559-562 ◽  
Author(s):  
Chunguang Sun ◽  
Matthew E Falagas ◽  
Rui Wang ◽  
Drosos E Karageorgopoulos ◽  
Xuhong Yu ◽  
...  

1994 ◽  
Vol 47 (4) ◽  
pp. 507-509 ◽  
Author(s):  
YOSHIYUKI KAWAKAMI ◽  
CHIZUMI FURUWATARI ◽  
TAKAYUKI AKAHANE ◽  
YUKIE OKIMURA ◽  
KEN''ICHI FURIHATA ◽  
...  

2014 ◽  
Vol 67 (5) ◽  
pp. 369-371 ◽  
Author(s):  
Yu Xu-hong ◽  
Matthew E Falagas ◽  
Wang Dong ◽  
Drosos E Karageorgopoulos ◽  
Lin De-feng ◽  
...  

Author(s):  
Asim Ali Shah ◽  
Shahid Ahmad Abbasi ◽  
Yasir Ali ◽  
Ayesha Maqbool

Abstract This descriptive cross-sectional study was performed in the Department of Microbiology, Fauji Foundation Hospital, Rawalpindi, from March 2019 to September 2019 to determine the in vitro efficacy of Daptomycin against clinical isolates of Methicillin-Resistant Staphylococcus aureus (MRSA). Consecutive non-probability sampling technique was used and a total number of 270 patients’ Pan Cultures having MRSA growth on Cefoxatin Disc with size less than 22 mm zone size were included in the study. Cultures were inoculated on MacConkey, Chocolate and Blood agar and then incubated for 24 hours at 37 degree Celsius. After incubation, Coagulase test, Catalase test and Gram staining technique were used for further identification. Minimum Inhibitory Concentration (MIC) of the isolates for Daptomycin was obtained by using E strips (Oxoid UK) according to Clinical & Laboratory Standards Institute (CLSI) guidelines. Continuous...  


Sign in / Sign up

Export Citation Format

Share Document